|
|
|
Volumn 3, Issue 11, 2005, Pages 849-850
|
|
Eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALEXION;
ANDROGEN;
COMPLEMENT COMPONENT C5;
COMPLEMENT COMPONENT C9;
CORTICOSTEROID;
ECULIZUMAB;
LACTATE DEHYDROGENASE;
MONOCLONAL ANTIBODY;
NITRIC OXIDE;
WARFARIN;
ANTICOAGULANT THERAPY;
BONE MARROW DEPRESSION;
CLINICAL FEATURE;
CLINICAL TRIAL;
COMPLEMENT SYSTEM;
DRUG EFFICACY;
DRUG INDICATION;
DRUG INFUSION;
DRUG TOLERABILITY;
ERYTHROCYTE TRANSFUSION;
FEVER;
HEADACHE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HEMOLYSIS;
HUMAN;
MENINGITIS;
NOTE;
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA;
PATHOGENESIS;
PILOT STUDY;
PROTEIN FUNCTION;
QUALITY OF LIFE;
RHEUMATOID ARTHRITIS;
SHIVERING;
SYSTEMIC LUPUS ERYTHEMATOSUS;
THROMBOCYTE ACTIVATION;
THROMBOSIS;
TREATMENT OUTCOME;
ANTIBODIES, MONOCLONAL;
CLINICAL TRIALS, PHASE III;
COMPLEMENT C5;
HEMOGLOBINURIA, PAROXYSMAL;
HUMANS;
PILOT PROJECTS;
PREDICTIVE VALUE OF TESTS;
THROMBOSIS;
TREATMENT OUTCOME;
|
|
EID: 29744436872
PISSN: 15430790
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (10)
|
|
References (5)
|
